---
title: "axamony"
output: pdf_document
---
---
title: 
output:
  pdf_document: default
  html_document: default
  word_document: default
---

![](cover.pdf)


# Introduction




# Question 1: What corporate governance mechanisms maz have served to improve the performance of MONY's management? Why have they apparently failed to do so?






# Question 2: What options are available to AXA to finance the takeover of MONY? Why has AXA chose to use ORANs?



# Question 3: How are ORANs price and what information do they communicate together with AXA's share price?


# Question 4: Why are MONY shares trading above AXA's offer prince, in the absence of any competing bid and with no apparent indication that AXA may raise its offer?




# Conclusion
